195 related articles for article (PubMed ID: 26796899)
1. Sugammadex approved to reverse NMBA effects.
Thompson CA
Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
[No Abstract] [Full Text] [Related]
2. [Sugammadex, a novel drug for neuromuscular blockade reversal].
Fernández Meré LA; Alvarez-Blanco M
Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):95-102. PubMed ID: 20337001
[TBL] [Abstract][Full Text] [Related]
3. Effects of sugammadex doses up to 32 mg/kg alone or in combination with rocuronium or vecuronium on QTc prolongation: a thorough QTc study.
de Kam PJ; van Kuijk J; Prohn M; Thomsen T; Peeters P
Clin Drug Investig; 2010; 30(9):599-611. PubMed ID: 20568829
[TBL] [Abstract][Full Text] [Related]
4. The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.
Gonzalez-Estrada A; Carrillo-Martin I; Morgenstern-Kaplan D; Garzon-Siatoya WT; Renew JR; Hernandez-Torres V; Volcheck GW
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):466-473.e5. PubMed ID: 36108924
[TBL] [Abstract][Full Text] [Related]
5. [Sugammadex: something new to improve patient safety or simply a gadget?].
Plaud B
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280
[TBL] [Abstract][Full Text] [Related]
6. Sugammadex and rocuronium-induced anaphylaxis.
Takazawa T; Mitsuhata H; Mertes PM
J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
[TBL] [Abstract][Full Text] [Related]
7. Rocuronium-induced anaphylaxis not improved by low dose sugammadex: a case report.
Hakozaki T; Murakawa M
Anaesth Intensive Care; 2016 Jul; 44(4):522. PubMed ID: 27456189
[No Abstract] [Full Text] [Related]
8. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
9. [Impact of sugammadex on neuromuscular blocking agents use: a multicentric, pharmaco-epidemiologic study in French university hospitals and military hospitals].
Beny K; Piriou V; Dussart C; Hénaine R; Aulagner G; Armoiry X;
Ann Fr Anesth Reanim; 2013 Dec; 32(12):838-43. PubMed ID: 24176722
[TBL] [Abstract][Full Text] [Related]
10. Sugammadex in the management of rocuronium-induced anaphylaxis.
McDonnell NJ; Pavy TJ; Green LK; Platt PR
Br J Anaesth; 2011 Feb; 106(2):199-201. PubMed ID: 21149287
[TBL] [Abstract][Full Text] [Related]
11. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
13. [Sugammadex: a new approach to muscle relaxation and its reversal].
Duvaldestin P
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S39-40. PubMed ID: 19887275
[No Abstract] [Full Text] [Related]
14. Worldwide experience with sugammadex sodium: implications for the United States.
Welliver M; Cheek D; Osterbrink J; McDonough J
AANA J; 2015 Apr; 83(2):107-15. PubMed ID: 26016169
[TBL] [Abstract][Full Text] [Related]
15. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
[TBL] [Abstract][Full Text] [Related]
16. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex and rocuronium-induced anaphylaxis.
Baldo B
Anaesthesia; 2012 Oct; 67(10):1174-5; author reply 1175. PubMed ID: 22950397
[No Abstract] [Full Text] [Related]
18. The concept behind sugammadex.
Epemolu O; Bom A
Rev Esp Anestesiol Reanim; 2014 May; 61(5):272-6. PubMed ID: 24636599
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of sugammadex].
Meistelman C; Fuchs-Buder T
Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278
[TBL] [Abstract][Full Text] [Related]
20. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs.
Mosing M; Auer U; West E; Jones RS; Hunter JM
Vet J; 2012 Jun; 192(3):467-71. PubMed ID: 22030475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
